Article Information
History
- September 18, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Author Information
- Holly Y. Chen1,†,
- Manju Swaroop2,‡,
- Samantha Papal1,‡,
- Anupam K. Mondal1,‡,
- Gregory J. Tawa2,
- Florian Regent1,
- Hiroko Shimada1,§,
- Kunio Nagashima3,
- Natalia de Val3,
- Samuel G. Jacobson4,
- Wei Zheng2 and
- Anand Swaroop1,*
- 1Neurobiology, Neurodegeneration and Repair Laboratory, National Eye Institute, National Institutes of Health; Bethesda, MD 20815, USA
- 2National Therapeutics for Rare and Neglected Diseases, National Center for Advancing Translational Sciences, National Institutes of Health; Rockville, MD 20850, USA
- 3Electron Microscopy Laboratory, National Cancer Institute, Center for Cancer Research, Leidos Biomedical Research, Frederick National Laboratory; Frederick, MD 21701, USA
- 4Department of Ophthalmology, Scheie Eye Institute, Perelman School of Medicine, University of Pennsylvania; Philadelphia, PA 19104, USA
- ↵*Corresponding author. E-mail: swaroopa{at}nei.nih.gov
↵‡ These authors contributed equally
Posted September 18, 2022.
Reserpine maintains photoreceptor survival in retinal ciliopathy by resolving proteostasis imbalance and ciliogenesis defects
